Xenetic Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.08

+0.00 (+0.00%)

As of Feb 8, 2:32 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,656.3% upside

Low Target $23.38

Average Target $36.53

High Target $47.42

Current Price $2.08

Current
$2.08

Target
$36.53

$23.38 $36.53 avg $47.42

Scenario Analysis

Bear Case

$23.38

1,024.0%

Low target

Base Case

$36.53

+1,656.3%

Avg target

Bull Case

$47.42

+2,179.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$33.65

-93.8% from high

52-Week Low

$17.16

+-87.9% from low

Target vs 52W High

$36.53

+8.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%